
United States · Medical practice startup
Prenuvo is a health technology company that specializes in advanced, radiation-free, and contrast-free whole-body MRI scans aimed at the early detection of cancer and other diseases.
Funding reportedLast round: Series A
Prenuvo is a health technology company that specializes in advanced, radiation-free, and contrast-free whole-body MRI scans aimed at the early detection of cancer and other diseases.
Founded in 2018, Prenuvo has its headquarters in Redwood City, California, with additional operations in Los Angeles and San Francisco. The company operates a network of patient-centric clinics across North America, Australia, and the UK, serving over 110,000 members and providing more than 1.4 million personalized health insights. Prenuvo's flagship service is the Whole-Body MRI Scan, which can detect early signs of over 500 types of cancers and diseases in under 60 minutes. The company has recently expanded its offerings to include new FDA-cleared health evaluations, such as a Comprehensive Blood Test, Neurological Scan, and Body Composition Analysis. Prenuvo's focus on preventive healthcare and its use of AI-driven analysis position it as a leader in the diagnostic imaging industry, promoting proactive health management for individuals and organizations alike.
Funding, as reported
From Prenuvo's own website: 4 on the team.
What they build
Known for
wellness initiativesai-driven health insightshealth carecomprehensive health assessmentfsa hsa eligibilitydigital healthmri technologyvoxel imagingquantitative imaginghealthcare analyticsnon-invasive proceduremedical data analyticspreventive health careai-powered health analyticsmedical imaging clinicsnon-invasive mri
Built with from their website
DockerAmazon SESAmazon DynamoDBGoogle Tag ManagerAmazon CloudFrontDell TechnologiesGoogle SheetsdbtSalesforce CRM AnalyticsHREF Lang
AtlassianPWAStripe PaymentsGoogle AdsFivetranYouTubeGitHubGoogle Workspace
Add your raise, your deck and your story, and put Prenuvo in front of investors. Or tell us what we have wrong.